SUMMARY A randomised double blind study was performed on 59 patients with dendritic herpetic keratitis treated with 3% acyclovir or 2% trifluorothymidine ointment. Both drugs were highly effective and gave 87% (ACV) and 82% (T1F') success rates. Punctate keratopathy occurred in 70% of the patients, but serious side effects were not observed.
Since the introduction of idoxuridine (IDU) as an antiviral drug for the treatment of herpetic keratitis more potent drugs have become available. Arabinoside adenine and trifluorothymidine (TFT) are both effective and relatively nontoxic alternatives widely used in the management of herpetic disease.' Acyclovir (ACV) (9-(2-hydroxyethoxymethyl) guanine)2 and (E)-5(2-bromovinyl)-2' deoxyuridine),3 recently developed antiviral compounds with potent inhibitory activity against herpes simplex DNA polymerase, do not inhibit normal human cell DNA polymerase.
For a comparative study we selected 2 of the antiviral drugs which we considered to be the most potent -acyclovir and trifluorothymidine.45 Material and methods Fifty-nine patients with dendritic keratitis were studied. Patients with stromal keratitis and patients treated by antiviral agents and/or corticosteroids prior to referral were excluded. In a randomised double-blind study we used 3% acyclovir and 2% trifluorothymidine ointment, both specially prepared for this trial and packed in identical tubes obtained through the kind co-operation of Wellcome Laboratories (England) and Dr Gerhard Mann, Hamburg (FRG), respectively. The ointment was prescribed 5 times daily. Cycloplegics were given for intraocular irritation.
After healing was complete the treatment was continued for 7 days. It was discontinued if after 7 days no therapeutic effect was observed or if after 14 days the keratitis had not healed completely.
Correspondence to Dr C. Ia The most frequently observed side effect was superficial punctate keratopathy, showing fluorescein staining outside the area of the herpetic lesions. This occurred in about 70% of patients in both groups, with an average duration of slightly more than one week. In both groups a few patients complained of a stinging sensation after application of the ointment, but extensive conjunctival hyperaemia was seen in only 3 patients receiving TFT, and it disappeared a few days after discontinuation of the treatment. In neither groups were there short-term recurrences of herpetic keratitis. Discussion groups had had their eye complaints days ( Table 2) .
The results are summarised in Fig. I (Table 3) . patients agree with the favourable results of ignificant. Nor experiments in rabbits.1 [7] [8] [9] [10] [11] Other results of clinical between the trials with 3% ACV ointment in dendritic or geoitment and the graphic herpetic keratitis are also favourable and vas started. agree with our results.`-`' The average healing time in our series of ACV-treated patients was 6-3 days, which is longer than the 4-4 days in the series of Collum et al. 3 In our preliminary study 20 ACV-treated patients had healed within 10 days,6 but in the present series 4 out of the 31 eyes failed to heal. In previous studies, totalling 84 ACV-treated eyes, the keratitis in all eyes I responded well to the treatment and healed.`-lS The lack of efficacy which we observed may have been caused by resistance against herpes virus strains comparable to that of strains refractory to TFT. But this cannot be proved because inadequate treatment could be the explanation in patients treated on an outpatients basis.
As this was a multicentre study, special care was taken to make a strict protocol and a proforma for wir ( 
